Literature DB >> 2995065

Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart.

J Z Xiang, W Linz, H Becker, D Ganten, R E Lang, B Schölkens, T Unger.   

Abstract

The role of converting enzyme (CE) in heart function was studied by assessing the inhibition of CE activity in rat heart tissue and in isolated perfused hearts from rat, guinea-pig and rabbit (Langendorff technique). Angiotensin I (ANG I) added to the perfusate reduced coronary flow (FLO) in all species, increased force of contraction (CON) in rats, decreased CON in guinea-pigs and had no effect on CON in rabbits. In contrast, bradykinin (BK) increased FLO in all species, decreased CON in rats, increased CON in guinea-pigs and had no effect on CON in rabbits. The CE inhibitors ramipril (HOE498) 1 mg/kg and enalapril (MK421) 30 mg/kg given orally 1 h prior to killing of the animals inhibited the ANG I effects and potentiated the BK effects but had no effects on the action of ANG II. The same doses of the two CE inhibitors produced up to 24 h inhibition of CE activity measured biochemically in the heart after single oral doses. Electrical sympathetic stimulation of the cardiac nerves (SNS) in isolated rabbit heart resulted in an increase of HR and CON and in an initial decrease and subsequent increase of FLO. The effects of SNS on HR and FLO were significantly reduced following HOE498 (1 mg/kg) pretreatment. The results suggest that local CE is involved in the regulation of peptide effects in the heart, including the ANG II-mediated facilitation of neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995065     DOI: 10.1016/0014-2999(85)90738-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

Review 1.  Newer ACE inhibitors. A look at the future.

Authors:  A Salvetti
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 2.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 3.  The renin-angiotensin-aldosterone system and cardiac ischaemia.

Authors:  H Ikram
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

4.  Influence of angiotensin converting enzyme inhibition on pump function and cardiac contractility in patients with chronic congestive heart failure.

Authors:  L H Baur; J J Schipperheyn; J Baan; A van der Laarse; B Buis; E E van der Wall; V Manger Cats; A D van Dijk; J A Blokland; M Frölich
Journal:  Br Heart J       Date:  1991-03

5.  Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.

Authors:  H Schunkert; V J Dzau; S S Tang; A T Hirsch; C S Apstein; B H Lorell
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

Authors:  D W Cushman; F L Wang; W C Fung; G J Grover; C M Harvey; R J Scalese; S L Mitch; J M DeForrest
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

7.  Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.

Authors:  Q Li; J Zhang; M Pfaffendorf; P A van Zwieten
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

8.  Enhanced cardiac angiotensinogen gene expression and angiotensin converting enzyme activity in tachypacing-induced heart failure in rats.

Authors:  M Finckh; W Hellmann; D Ganten; A Furtwängler; J Allgeier; M Boltz; J Holtz
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

9.  Losartan inhibits myosin isoform shift after myocardial infarction in rats.

Authors:  Mei Luo Zhang; Samer Elkassem; Allen W Davidoff; Kaoru Saito; Henk E D J ter Keurs
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

10.  Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor.

Authors:  R Chahine; A Adam; N Yamaguchi; R Gaspo; D Regoli; R Nadeau
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.